InspireMD

$0.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0883 (-11.25%) Today
-$0.0167 (-2.40%) As of 11:59 PM UTC after-hours

Why Robinhood?

You can buy or sell InspireMD and other stocks, options, and ETFs commission-free!

About NSPR

InspireMD, Inc., also called InspireMD, is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel. The listed name for NSPR is InspireMD, Inc.

CEO
Marvin L. Slosman
Employees
48
Headquarters
Tel Aviv, Tel Aviv
Founded
2005
Market Cap
84.91M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
14.74M
High Today
$0.7749
Low Today
$0.65
Open Price
$0.745
Volume
11.44M
52 Week High
$1.48
52 Week Low
$0.282

NSPR Earnings

-$2.00
-$1.33
-$0.67
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 9, Pre-Market

You May Also Like

DOMO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure